Theme Monitoring Response to Immunotherapy (iRECIST)

General

The objective of this webinar series is to create a platform for international stakeholders to discuss critical topics and challenges they face when treating patients with immunotherapy, with a key goal of providing education and bringing awareness to the barriers currently impeding equitable access to IO around the globe. 

Moderator: Bachir Taouli, MD, MS - Icahn School of Medicine at Mount Sinai

Faculty:

  • Laurent Dercle, MD, PhD - Columbia University Irving Medical Center
  • Viktoriya Paroder, MD, PhD - Memorial Sloan Kettering Cancer Center

Webinar 5/6 content:

This webinar will examine the importance of assessing tumor response to immunotherapy with currently available tools, primarily iRECIST, and how they compare to RECIST and WHO criteria. The program will feature discussions from leading scientists and radiologists in the field of IO on how feasible these tools are in a clinical setting outside of a clinical trial and most importantly, in resource limited settings.

Date and Location

Time From 6.00 pm to 7.30 pm
Duration 1.5 hours
Start date Wednesday, October 16, 2024
Location Online

Costs and registration

Register here for this free webinar series.